IDEX Health & Science has an employee rating of 3.8 out of 5 stars, based on 46 company reviews on Glassdoor which indicates that most employees have a good working experience there. The IDEX Health & Science employee rating is in line with the average (within 1 standard deviation) for employers within the Manufacturing industry (3.5 stars).
IDEX health and science is a good company to work for the benefits are reasonable. The advancements and the professional growth are encouraged and the people are a great team to work with.
Cons
Idexx health and science also has its shortcomings. It has a lack of consistent communication from the top down. It has a very slow growth rate when it comes to salary and pay increases.
-Great work-life balance
-Remote work opportunities
-Lots to learn and very interesting adjacent fields
Cons
There is very stiff upper management and change to processes is very minimal and unheard of. Communication between teams can be very rickety and often fails.
Check out your Company Bowl for anonymous work chats.
Bowls
Get actionable career advice tailored to you by joining more bowls.
Followed companies
Stay ahead in opportunities and insider tips by following your dream companies.
Job searches
Get personalised job recommendations and updates by starting your searches.
IDEX Health & Science reviews FAQs
According to anonymously submitted Glassdoor reviews, IDEX Health & Science employees rate their compensation and benefits as 3.9 out of 5. Find out more about salaries and benefits at IDEX Health & Science. This rating has decreased by 2% over the last 12 months.
66% of IDEX Health & Science employees would recommend working there to a friend based on Glassdoor reviews. Employees also rated IDEX Health & Science 3.6 out of 5 for work life balance, 3.6 for culture and values and 3.4 for career opportunities.
Explore Glassdoor’s employee reviews to understand what current and former employees are saying about IDEX Health & Science redundancy and their outlook for job security at IDEX Health & Science in 2026.